Digital Health Platform Eysz Now Seeking Funds Through RegCF Campaign on Bioverge Portal


Eysz, a U.S.-based digital health platform, recently launched its Regulation Crowdfunding (RegCF) campaign on investment platform Bioverge.  Founded in 2018, Eysz stated it is developing a digital health platform to enable personalized medicine for neurological disorders, starting with epilepsy.

We exist because we want to positively impact the lives of the 70 Million people with epilepsy. We know that 70% of them can live seizure free if they had the proper diagnosis and treatment. We are a team of doctors and doers that are on a mission to develop and deploy our AI-based clinical decision support tool that analyzes passive eye-movements to give clinicians the data they need to effectively manage the neurological health of their patients…starting with Epilepsy first.”

Eysz also revealed it is developing an AI-based software solution that analyzes passive eye movements from compatible eye-tracking systems to assist clinicians in understanding their patient’s seizure burden and neurocognitive side effects, enabling them to create a more personalized care plan. Rachel Kuperman, MD, Founder and CEO of Eysz, shared more details about the company’s progress by stating:

“Our goal is to help bridge the communication gap between patients with epilepsy and their doctors by supplementing patient reported data with objective remote monitoring data to improve outcomes and quality of life. We’re very excited about the progress we’ve made in the research and development of our software, including the completion of a proof-of-concept study and the launch of our multi-center clinical study.”

Kuperman then reported that the funding round will provide her team with the means to advance their technology towards regulatory clearance and commercialization.

“[The investment] provides a great opportunity to expand the investment opportunity to the community we hope to serve as well as traditional investors.”

Since its launch, Eysz’s campaign has raised nearly $100,000 from 55 investors. The company’s pre-valuation was $15 million and will be up to $18 million by July 2021. 

Have a crowdfunding offering you'd like to share? Submit an offering for consideration using our Submit a Tip form and we may share it on our site!

Sponsored Links by DQ Promote


Send this to a friend